Riskpilot← Back to searchSign inGet full accessTervix AB
ABDissolvedOrg 5562301639Publishing of books · NACE 5811Est. 19831 employees
Revenue 2023
SEK 50K
-52% vs 2022
EBITDA margin
0.6%
+103% vs 2022
Equity ratio
59.6%
Financial strength
Net profit 2023
SEK 970
+107% vs 2022
| Revenue | SEK 50K | -52% |
| EBITDA | SEK 305 | +103% |
| Net profit | SEK 970 | +107% |
| Total assets | SEK 509K | +4% |
| Equity | SEK 304K | +0% |
| Employees | 1 | — |
Legal name
Tervix AB
Org number
5562301639
Legal form
Aktiebolag
NACE code
5811 · Publishing of books
Founded
7 juni 1983
Share capital
SEK 600 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva rådgivning vad gäller företagsledning, att bedriva upplysningsverksamhet om företagsutveckling, att bedriva webbutveckling, att bedriva förlagsverksamhet, att förvärva, förvalta och sälja aktier och fast egendom samt utföra därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 32 | 211 | 78 | 105 | 50 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −145 | −30 | −101 | −9 | 0 |
| Depreciation & amort. | −43 | −29 | −0 | −0 | — |
| EBIT | −188 | −59 | −101 | −9 | 0 |
| Net financials | −740 | 56 | 2 | −10 | 1 |
| Profit before tax | −508 | 4 | −99 | −14 | 1 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −508 | 4 | −99 | −14 | 1 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 496 | 688 | 559 | 490 | 509 |
| Equity | 311 | 316 | 317 | 303 | 304 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 185 | 372 | 242 | 187 | 206 |
| Total debt | 185 | 372 | 242 | 187 | 206 |
EBITDA margin
0.6%
This company
15.8%
Market median
-96% vs market
20192023
Equity ratio
59.6%
This company
38.2%
Market median
+56% vs market
20192023
Return on equity
0.3%
This company
18.4%
Market median
-98% vs market
20192023
Net profit margin
1.9%
This company
8.1%
Market median
-77% vs market
20192023
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20192023
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SR Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tervix AB
Tervix AB Board members of Tervix AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Roland Ottosson | Chief Executive Officer | 0 companies |
| Erik Johan Längström | Deputy Board Member | 0 companies |